🔎 Trials Near Me

Home › Hemangiosarcoma

Hemangiosarcoma clinical trials recruiting in the U.S.

5 studies for Hemangiosarcoma are recruiting participants at sites across the United States.

By state

Recently updated studies

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06440005

Intratumoral Vusolimogene Oderparepvec (VO) in Combination With Pembrolizumab for Angiosarcoma

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 1, 2026 · NCT06898970

A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 12, 2026 · NCT05859074

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 6, 2026 · NCT01042379

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.